Your browser doesn't support javascript.
loading
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Li, Lingzhi; Nie, Lei; Jordan, Alexa; Cai, Qingsong; Liu, Yang; Li, Yijing; Che, Yuxuan; Vargas, Jovanny; Chen, Zhihong; Leeming, Angela; Wang, Wei; Yao, Yixin; Wang, Michael; Jiang, Vivian Changying.
Afiliação
  • Li L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Nie L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Jordan A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Cai Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Li Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Che Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Vargas J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Leeming A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Wang W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center.
  • Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.
  • Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center. cjiang@mdanderson.org.
Haematologica ; 108(6): 1616-1627, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36420799

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article